1. Mehta H: Ambien ® (zolpidem) tablets BPCA Drug Use Review. Department of Health and Human Services, Public Health Service FDA, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology. 2008
2. Benkert O, Hippius H: Kompendium der Psychiatrischen Pharmakotherapie. Springer Verlag, Heidelberg 2012, pp.431–434
3. McKerman RM, Rosahl TW, Reynolds DS et al.: Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAa receptor alpha1 subtype. Nat Neurosci 2000; 3: 587–592
4. Visser SA, Wolters FL, van der Graaf PH et al.: Dose-dependent EEG effect of zolpidem provide evidence for GABAa receptor subtype selectivity in vivo. J Pharmacol Exp Ther 2003; 304: 1251–1257
5. Deporteere H, Zivkovic B, Lloyd KG et al.: Zolpidem, a novel nonbenzodiazepin hypnotic. Neuropharmacological and behavioural effects. J Pharmacol Exp Ther 1986; 237: 649–658